Zemits EvoPlasm

Zemits has launched EvoPlasm in the UK, a new professional cold plasma device designed to enhance advanced facial, skin rejuvenation, body and scalp treatments.

Developed for aesthetic clinics, skin specialists and professional treatment rooms, EvoPlasm uses Cold Atmospheric Plasma technology to create gentle surface ionisation across the skin. The device is designed to support clearer, brighter and more refined-looking skin without heat, needles, trauma or downtime.

The launch positions cold plasma as a versatile treatment add-on that can be integrated into existing protocols rather than used only as a stand-alone service. Zemits says EvoPlasm can be used alongside hydrodermabrasion, oxygen therapy, LED, chemical peels, radiofrequency-based treatments, microneedling and restorative facial protocols.

EvoPlasm has been developed to support three key cosmetic effects: skin-clarifying action, enhanced topical delivery and skin-conditioning stimulation. The brand says the treatment helps reduce the appearance of surface impurities, improves the skin’s ability to receive cosmetic products and supports the skin’s natural renewal process for a smoother, more balanced-looking complexion.

The device offers four adjustable intensity levels, allowing practitioners to tailor treatments according to the client’s skin type, sensitivity and treatment goal. It also includes two working modes: Constant Mode for stronger stimulation and Pulse Mode for sensitive or first-time clients.

Zemits positions EvoPlasm as a no-consumable technology, meaning there are no disposable tips, single-use accessories or dedicated serums required to operate the device. This makes it commercially relevant for clinics looking to add value to existing treatments without increasing ongoing material costs.

The brand also highlights the device’s compatibility with face, body and scalp protocols, including post-treatment skin support, chemical peel recovery, hydrodermabrasion, LED, RF skin treatments and scalp-focused services. For clinics, this creates an opportunity to position cold plasma as an upgrade within multiple treatment categories.

According to Zemits UK director Ulyana Danyleyko, today’s aesthetic practitioners are looking for technologies that integrate seamlessly into existing protocols. She said EvoPlasm was selected for the UK market because it offers versatility, treatment compatibility and a sophisticated approach to skin support.

Zemits EvoPlasm is available through Zemits UK.